Pay in 4 interest-free payments of $7.47 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
4 GLP-1R clinical trial progress 4.1 GLP-1R agonists in the treatment of DM GLP-1R agonists have emerged as a significant therapeutic agent in the management of diabetes
He simply wants to make each day a little better than yesterday
Evidence-based treatment for fatty liver disease prioritises 710% body weight loss, dietary changes, and management of diabetes and dyslipidaemia
Do oral peptides require post-cycle therapy (PCT)
CAT No: 10-101-343 CAS No: 1401708-83-5 Synonyms/Alias: dihexa;1401708-83-5;L-Isoleucinamide, N-(1-oxohexyl)-L-tyrosyl-N-(6-amino-6-oxohexyl)-;N-hexanoic-Tyr-Ile-(6) aminohexanoic amide;9WYX65A5C2;PNB-0408;(2S,3S)-N-(6-amino-6-oxohexyl)-2-[[(2S)-2-(hexanoylamino)-3-(4-hydroxyphenyl)propanoyl]amino]-3-methylpentanamide;6-(2-(2-Hexanamido-3-(4-hydroxyphenyl)propanamido)-3-methylpentanamido)hexanamide;6-[(2S,3S)-2-[(2S)-2-hexanamido-3-(4-hydroxyphenyl)propanamido]-3-methylpentanamido]hexanamide;Hexanoyl-Tyr-Ile-Ahx-NH2;UNII-9WYX65A5C2;Dihexa (PNB-0408)?;DTXSID701032895;GLXC-25923;ATH-1001;AKOS040759118;CS-6864;DA-62870;HY-16969;PNB-0408
US$ 22.59
US$ 24.25
US$ 29.13
US$ 26.94
US$ 27.22
US$ 20.67
US$ 29.45
US$ 19.99
